It’s extremely rewarding to work in one of the largest and most diverse global business sectors helping support clients to realize their goals.
Matthew provides mergers and acquisitions (M&A) advisory services and leads Lincoln’s U.K. strategic efforts within the healthcare sector. Matthew has nearly 20 years of M&A advisory experience, executing both sell-side and buy-side transactions for private equity clients, publicly traded companies and privately held and family-owned businesses. His experience spans both U.K. and international markets.
Matthew specializes in advising healthcare services and medical device companies and has a comprehensive understanding of these diverse markets. Matthew delivers on clients’ ambitions by providing hands-on, independent advice and leveraging the global Lincoln healthcare network.
Prior to joining Lincoln, Matthew worked at one of the “Big 4” accountancy firms as a senior member of its healthcare M&A team. Beforehand, Matthew was a private equity investor at Lloyds Development Capital and practiced healthcare M&A at Rothschild & Co in London.
Matthew earned a Bachelor of Science from the University of Bath and holds a Securities Institute Diploma.
Lincoln International is pleased to announce that Bridges Fund Management has sold The Vet to CVS Group plc
Lincoln International has advised Medux, a portfolio company of NPM Capital, on the acquisition of Medequip
Lincoln International is pleased to announce that it has advised Westbridge Capital on the sale of AJM Healthcare to Livingbridge
Lincoln International represents Sovereign Capital Partners in its sale of Linnaeus Group to Mars Inc.
Lincoln International represents RIG Healthcare in its sale to Cpl Resources plc
Lincoln International advises the private equity investors Granville and Baird Capital in the sale of Amoena Group to Halder
Lincoln International represents Altaris Capital Partners in the sale of Penlon Ltd. to Goldman Sachs backed BPL Medical Technologies Private Ltd.
Perspectives featuring Matthew Lee
Outsourced Healthcare Logistics: Ripe for Private Equity Investment
Ample consolidation opportunity for private equity (PE) to capitalize on accelerating healthcare trends and consistent well-above GDP growth rates Favorable market fundamentals supporting the mid-and-long-term outlook for healthcare third-party… Read More
Event | Economic and Healthcare Spending
On 6 November 2021, the Lincoln International Healthcare team hosted a C-Suite focused evening at Dartmouth House in Mayfair, co-sponsored by CIL Consulting and Global Counsel, with guest speakers David… Read More
Animal Health Players Pursue Vertical Integration as a Path to Growth
Animal health businesses that have established a strong presence within their area of expertise, may be considering where the next best path to growth lies. While cross-border expansion and consolidation… Read More
Cross-Border Deals: The Right Prescription for Animal Health
As the humanization of pets continues and pet lifespans grow longer, investment opportunities in animal health abound. While most animal health companies will first look for growth within their own… Read More
News & Media featuring Matthew Lee
The Pharmaceutical Journal | Is Amazon Really a Threat to the UK Pharmacy Market?
Matthew Lee, Managing Director at Lincoln International joins the Pharmaceutical Journal deputy news editor, Carolyn Wickware, in a recent episode of The PJ Pod to share his thoughts on the… Read More
Pitchbook | Q&A: The Evolution of Medtech in a Globalizing Industry
View original post from Pitchbook on May 29, 2019 here. … Read More
Meet our Senior Team
I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.
Managing Director | Management Board MemberFrankfurt